Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
+$784M |
| 2 |
Amgen
AMGN
|
+$695M |
| 3 |
Eli Lilly
LLY
|
+$512M |
| 4 |
Apple
AAPL
|
+$485M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$471M |
Top Sells
| 1 |
Adobe
ADBE
|
+$935M |
| 2 |
NVIDIA
NVDA
|
+$837M |
| 3 |
TJX Companies
TJX
|
+$533M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$364M |
| 5 |
Starbucks
SBUX
|
+$357M |
Sector Composition
| 1 | Technology | 35.94% |
| 2 | Healthcare | 18.89% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Sprinklr
CXM
$1.92B
| $376K | ﹤0.01% |
39,078
-622
| -2% | -$5.99K |
|
2102
BlueLinx
BXC
$634M
| $375K | ﹤0.01% |
4,037
-43
| -1% | -$4K |
|
2103
Protolabs
PRLB
$1.19B
| $375K | ﹤0.01% |
12,160
-132
| -1% | -$4.07K |
|
2104
Sphere Entertainment
SPHR
$1.86B
| $375K | ﹤0.01% |
10,692
-129
| -1% | -$4.52K |
|
2105
Amneal Pharmaceuticals
AMRX
$3.1B
| $374K | ﹤0.01% |
58,800
-570
| -1% | -$3.62K |
|
2106
Southside Bancshares
SBSI
$919M
| $374K | ﹤0.01% |
13,532
-147
| -1% | -$4.06K |
|
2107
Interface
TILE
$1.6B
| $373K | ﹤0.01% |
25,431
-292
| -1% | -$4.29K |
|
2108
United Natural Foods
UNFI
$1.73B
| $371K | ﹤0.01% |
28,316
-299
| -1% | -$3.92K |
|
2109
Fox Class A
FOXA
$26.3B
| $370K | ﹤0.01% |
10,778
-10,472
| -49% | -$360K |
|
|
SVC
2110
Service Properties Trust
SVC
$472M
| $370K | ﹤0.01% |
72,269
-837
| -1% | -$4.29K |
|
2111
AMERISAFE
AMSF
$867M
| $370K | ﹤0.01% |
8,435
-97
| -1% | -$4.25K |
|
2112
A10 Networks
ATEN
$1.26B
| $369K | ﹤0.01% |
26,678
-357
| -1% | -$4.94K |
|
2113
Cipher Mining
CIFR
$3.6B
| $368K | ﹤0.01% |
+88,700
| New | +$368K |
|
2114
Perella Weinberg Partners
PWP
$1.4B
| $366K | ﹤0.01% |
22,594
-68,121
| -75% | -$1.1M |
|
2115
Ocular Therapeutix
OCUL
$2.24B
| $366K | ﹤0.01% |
+53,500
| New | +$366K |
|
2116
Tilray
TLRY
$1.24B
| $365K | ﹤0.01% |
219,391
| – | – |
|
2117
Emcor
EME
$28B
| $365K | ﹤0.01% |
1,000
-36,611
| -97% | -$13.4M |
|
2118
TechTarget
TTGT
$415M
| $365K | ﹤0.01% |
11,734
-132
| -1% | -$4.11K |
|
2119
Liberty Live Group Series A
LLYVA
$8.93B
| $363K | ﹤0.01% |
9,700
-100
| -1% | -$3.75K |
|
2120
Cytek Biosciences
CTKB
$513M
| $361K | ﹤0.01% |
64,873
-601
| -0.9% | -$3.35K |
|
2121
PRA Group
PRAA
$663M
| $361K | ﹤0.01% |
18,385
-196
| -1% | -$3.85K |
|
2122
Sabre
SABR
$679M
| $358K | ﹤0.01% |
134,372
-1,944
| -1% | -$5.18K |
|
2123
Viridian Therapeutics
VRDN
$1.63B
| $357K | ﹤0.01% |
27,472
+14,051
| +105% | +$183K |
|
2124
BrightView Holdings
BV
$1.3B
| $357K | ﹤0.01% |
26,832
+10,497
| +64% | +$140K |
|
2125
UiPath
PATH
$6.31B
| $356K | ﹤0.01% |
28,137
-2,032
| -7% | -$25.7K |
|